Probable tirofiban-induced thrombotic microangiopathy after stent thrombosis: a case report

BACKGROUND: Glycoprotein (GP) IIb–IIIa inhibitors are antithrombotic drugs used in selected patients during and after percutaneous coronary interventions (PCIs), usually as a bail-out in the setting of no-reflow or thrombotic complications. A notorious life-threatening adverse effect of this drug cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattioli, Maria, Paoli, Giorgia, Cambò, Benedetta, Bonura, Rosario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Grand Round
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874025/
https://www.ncbi.nlm.nih.gov/pubmed/36713264
http://dx.doi.org/10.1093/ehjcr/ytad005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874025/
https://www.ncbi.nlm.nih.gov/pubmed/36713264
http://dx.doi.org/10.1093/ehjcr/ytad005

Ejemplares similares